Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test.
作者信息
Lonardo Amedeo, Romagnoli Dante
机构信息
Outpatient Liver Clinic & Internal Medicine, Nuovo Ospedale Civile Sant'Agostino Estense (NOCSAE), Baggiovara, Modena, Italy.
出版信息
Indian J Med Res. 2016 Jan;143(1):4-7. doi: 10.4103/0971-5916.178574.
Abstract
摘要
相似文献
1
Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test.
Indian J Med Res. 2016 Jan;143(1):4-7. doi: 10.4103/0971-5916.178574.
2
Role of γ-glutamyl transferase levels in prediction of high cardiovascular risk among patients with non-alcoholic fatty liver disease.
Indian J Med Res. 2016 Jan;143(1):30-6. doi: 10.4103/0971-5916.178585.
3
Estimation of gamma-glutamyl transferase as a suitable simple biomarker of the cardiovascular risk in children with non-alcoholic fatty liver disease.
Acta Biochim Pol. 2018 Oct 31;65(4):539-544. doi: 10.18388/abp.2018_2611.
4
Gamma glutamyl transferase 'To be or not to be' a liver function test?
Ann Clin Biochem. 2016 Nov;53(6):629-631. doi: 10.1177/0004563216659887. Epub 2016 Jul 20.
5
The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
Oncotarget. 2017 Apr 25;8(17):28641-28649. doi: 10.18632/oncotarget.16162.
6
Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Metabolism. 2016 May;65(5):783-793. doi: 10.1016/j.metabol.2015.12.008. Epub 2015 Dec 21.
7
Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study.
Lipids Health Dis. 2018 Dec 13;17(1):284. doi: 10.1186/s12944-018-0932-0.
8
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
Diabet Med. 2018 Oct;35(10):1434-1439. doi: 10.1111/dme.13697. Epub 2018 Jun 22.
9
Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
Korean J Intern Med. 2016 May;31(3):479-87. doi: 10.3904/kjim.2015.253. Epub 2016 Mar 30.
10
Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease.
J Biol Regul Homeost Agents. 2011 Jan-Mar;25(1):47-56.
引用本文的文献
1
Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures.
Orphanet J Rare Dis. 2022 Dec 22;17(1):445. doi: 10.1186/s13023-022-02597-y.
2
Non-linear relationship between gamma-glutamyl transferase and type 2 diabetes mellitus risk: secondary analysis of a prospective cohort study.
J Int Med Res. 2020 Jul;48(7):300060520937911. doi: 10.1177/0300060520937911.
3
Associations of serum liver enzyme levels and their changes over time with all-cause and cause-specific mortality in the general population: a large-scale national health screening cohort study.
BMJ Open. 2019 Jun 1;9(5):e026965. doi: 10.1136/bmjopen-2018-026965.
4
Nonalcoholic fatty liver disease: Evolving paradigms.
World J Gastroenterol. 2017 Sep 28;23(36):6571-6592. doi: 10.3748/wjg.v23.i36.6571.
本文引用的文献
1
Role of γ-glutamyl transferase levels in prediction of high cardiovascular risk among patients with non-alcoholic fatty liver disease.
Indian J Med Res. 2016 Jan;143(1):30-6. doi: 10.4103/0971-5916.178585.
2
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.
Dig Liver Dis. 2015 Mar;47(3):181-90. doi: 10.1016/j.dld.2014.09.020. Epub 2014 Nov 18.
3
Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
Atherosclerosis. 2015 Feb;238(2):356-64. doi: 10.1016/j.atherosclerosis.2014.12.045. Epub 2014 Dec 23.
4
Relationships of elevated levels of serum hepatic enzymes and alcohol intake with arterial stiffness in men.
Atherosclerosis. 2015 Jan;238(1):83-8. doi: 10.1016/j.atherosclerosis.2014.11.021. Epub 2014 Nov 22.
5
The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.
J Hepatol. 2015 Apr;62(4):841-7. doi: 10.1016/j.jhep.2014.11.024. Epub 2014 Nov 27.
6
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.
Expert Rev Gastroenterol Hepatol. 2015 May;9(5):629-50. doi: 10.1586/17474124.2015.965143. Epub 2014 Oct 20.
7
Lack of association between serum gamma-glutamyltransferase and carotid atherosclerosis: the Namwon Study.
Atherosclerosis. 2014 Nov;237(1):268-72. doi: 10.1016/j.atherosclerosis.2014.09.019. Epub 2014 Sep 30.
8
Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
Atherosclerosis. 2014 Sep;236(1):7-17. doi: 10.1016/j.atherosclerosis.2014.06.006. Epub 2014 Jun 23.
9
Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects.
Dig Dis Sci. 2014 Oct;59(10):2470-6. doi: 10.1007/s10620-014-3214-3. Epub 2014 May 27.
10
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.
World J Gastroenterol. 2014 Feb 21;20(7):1724-45. doi: 10.3748/wjg.v20.i7.1724.
Zotero 插件